Increased TGFβ type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells

Experimental Cell Research

Volumn 255, Issue 1, 2000, Pages 77-85

  Turco, Alessandra ^a   Scarpa, Susanna ^b   Coppa, Anna ^b   Baccheschi, Gianluca ^a   Palumbo, Camilla ^b   Leonetti, Carlo ^c   Zupi, Gabriella ^c   Colletta, Giulia ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Neuroblastoma cells; Neuronal markers; TGF ; T RII

Indexed keywords

COMPLEMENTARY DNA; NEUROFILAMENT PROTEIN; NEUROMODULIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; PHENOTYPE; PRIORITY JOURNAL; REPORTER GENE; ANIMAL; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MOUSE; NEUROBLASTOMA; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION; GENES, REPORTER; HUMANS; MALE; MICE; MICE, NUDE; NEUROBLASTOMA; PHENOTYPE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034711879     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4750     Document Type: Article

References (33)

1. Bolande, R. P. (1974). The neurocristopathies: A unifying concept of disease arising in neural crest maldevelopment. Hum. Pathol. 5, 409-429.
2. Brodeur, G. M., and Nakagawa, A. (1992). Molecular basis of clinical heterogeneity in neuroblastoma. Am. J. Pediatr. Hematol. Oncol. 14, 111-116.
3. Snider, W. D. (1994). Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 77, 627-638.
4. Moses, H. L. (1996). Regulation of differentiation by TGFβ. Curr. Opin. Genet. Dev. 6, 581-586.
5. Shah, N. M., Groves, A. K., and Anderson, D. J. (1996). Alternative neural crest cell fates are instructively promoted by TGFb superfamily members. Cell 85, 331-343.
6. Rogers, S. L., Cutts, J. L., Gegick, P. J., McGuire, P. G., Rosenberger, C., and Krisinski, S. (1994). Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines. Exp. Cell Res. 211, 252-262.
7. Cohen, P. S., Letterio, J. J., Gaetano, C., Chan, J., Matsumoto, K., Sporn, M. B., and Thiele, C. J. (1995). Induction of transforming growth factor β1 and its receptors during all-transretinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res. 55, 2380-2386.
8. Scarpa, S., Coppa, A., Ragano-Caracciolo, M., Mincione, G., Giuffrida, A., Modesti, A., and Colletta, G. (1996). Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma. Exp. Cell Res. 229, 147-154.
9. McCune, B. K., Patterson, K., Chandra, R. S., Kapur, S., Sporn, M. B., and Tsokos, M. (1993). Expression of transforming growth factor isoforms in small round cell tumors of childhood. An immunohistochemical study. Am. J. Pathol. 142, 49-59.
10. Filmus, J., and Kerbel, R. S. (1993). Development of resistance mechanisms to the growth inhibitory effects of TGF β during tumor progression. Curr. Opin. Oncol. 5, 123-129.
11. Serra, R., and Moses, H. L. (1996). Tumor suppressor genes in the TGFβ signaling pathway. Nature 2, 390-391.
12. Markowitz, S. D., and Roberts, A. B. (1996). Tumor suppressor activity of the TGFβ pathway in human cancers. Cytokine Growth Factor Rev. 7, 93-102.
13. Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., and Brattain, M. G. (1994). Expression of TGFβ type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 269, 26449-26455.
14. Chang, J., Park, K., Bang, Y. J., Kim, W. S., Kim, D., and Kim, S. J. (1997). Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 57, 2856-2859.
15. Scarpa, S., Mincione, G., Ragano-Caracciolo, M., Modesti, A., and Colletta, G. (1994). Transforming growth factor alpha modulates replication and differentiation markers on a human neuroblastoma. Int. J. Oncol. 5, 547-552.
16. Turco, A., Coppa, A., Aloe, S., Baccheschi, G., Morrone, S., Zupi, G., and Colletta, G. (1999). Overexpression of transforming growth factor β type II receptor reduces tumorigenicity and metastatic potential of K-Ras-transformed thyroid cells. Int. J. Cancer 80, 85-91.
17. Geran, R. I., Greenberg, N. H., Macdonald, M. M., Shumacher, A. M., and Abbott, B. J. (1972). Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep. 3, 1-88.
18. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994). Mechanisms of activation of the TGFβ receptors. Nature 370, 341-346.
19. Lin, H. Y., Moustakas, A., Knaus, P., Wells, R. G., Henis, Y. I., and Lodish, H. F. (1995). The soluble exoplasmic domain of type II transforming growth factor (TGF-β) receptor. J. Biol. Chem. 270, 2747-2754.
20. Massagué, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641.
21. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, M., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta. Proc. Natl. Acad. USA 89, 5408-5412.
22. Hsing, A. Y., Kadomatsu, K., Bonham, M. J., and Danielpour, D. (1996). Regulation of apoptosis induced by transforming growth factor β1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res. 56, 5146-5149.
23. Inagaki, M., Moustakas, A., Lin, H. Y., Lodish, H. F., and Carr, B. I. (1993). Growth inhibition by TGF β type I is restored in TGF β-resistant hepatoma cells after expression of TGF β receptor type II cDNA. Proc. Natl. Acad. Sci. USA 90, 5359-5363.
24. Markowitz, S. D., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutter Baugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. W. V. (1995). Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 269, 1336-1338.
25. Coppa, A., Mincione, G., Lazzereschi, D., Ranieri, A., Turco, A., Lucignano, B., Scarpa, S., Ragano-Caracciolo, M., and Colletta, G. (1997). Restored expression of transforming growth factor β type II receptor in k-ras transformed thyroid cells, TGF β-resistant, reverts their malignant phenotype. J. Cell. Physiol. 172, 200-208.
26. Kageyama, H., Seki, N., Yamada, S., Sakiyama, S., and Nakagawara, A. (1998). DPC4 splice variants in neuroblastoma. Cancer Lett. 122, 187-193.
27. Kong, X. T., Choi, S. H., Inoue, A., Xu, F., Chen, T., Takita, J., Yokota, J., Bessho, F., Yanagisawa, M., Hanada, R., Yamamoto, K., and Hayashi, Y. (1998). Expression and mutational analysis of the DCC, DPC4 and MADR2/JV18-1 genes in neuroblastoma. Cancer Res. 57, 3772-3778.
28. Sidell, N., Altman, A., Haussler, M. R., and Seeger, R. C. (1983). Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp. Cell Res. 148, 21-30.
29. Negroni, A., Scarpa, S., Romeo, A., Ferrari, S., Modesti, A., and Raschella, G. (1991). Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ. 2, 511-518.
30. Shea, T. B., Sihag, R. K., and Nixon, R A. (1988). Neurofilament triplet proteins of NB2a/d1 neuroblastoma: Post-translational modification and incorporation into the cytoskeleton during differentiation. Brain Res. 43, 97-109.
31. Geiser, A., Burmester, A., Webbink, R., Roberts, R. B., and Sporn, M. B. (1992). Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J. Biol. Chem. 276, 2588-2593.
32. Stampfer, M. R., Yaswen, P., Alhadeff, M., and Hosoda, J. (1993). TGFβ induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J. Cell. Physiol. 155, 210-221.
33. Coppa, A., Mincione, G., Mammarella, S., Ranieri, A., and Colletta, G. (1995). Epithelial rat thyroid cells, escaping from TGF β negative growth control, are still inhibited by this factor in the ability to trap iodide. Cell Growth Differ. 6, 281-290.